NIH-funded research R01 grant

Using advanced MRI techniques to study sodium levels in mild brain injuries

Official title: Optimized Sodium MR Imaging at Clinical Field Strength to Study in vivo Sodium Signal in Mild Traumatic Brain Injury

Funded at New York University School of Medicine · NIH-11058399 · Data updated 2026-11-12

This study is looking at how new MRI techniques can help us understand brain changes in people with Mild Traumatic Brain Injury (MTBI) by measuring sodium levels, which could lead to better treatments for this common condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startApril 25, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$620,173
NIH project number5R01NS131458-03
Project IDNIH-11058399 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Mild Traumatic Brain Injury.

Less likely to help

Patients with severe traumatic brain injuries or other neurological conditions unrelated to MTBI may not benefit from this research.

What this research studies

This research focuses on utilizing advanced sodium MRI (NaMRI) and proton diffusion MRI to identify imaging biomarkers in patients with Mild Traumatic Brain Injury (MTBI). By measuring sodium levels in the brain, the study aims to uncover the underlying mechanisms of MTBI, which has been a significant public health issue. The research leverages recent technological advancements to improve the signal quality of NaMRI, making it feasible to study clinical populations. The findings could lead to new treatment pathways for MTBI, addressing the current gaps in understanding and managing this condition.

Why it matters

Potential benefit: If successful, this research could provide critical insights into the mechanisms of mild traumatic brain injury and pave the way for new treatment options.

How similar studies have gone: Previous studies have shown promising results in using sodium channel blockade in animal models of MTBI, indicating potential for success in this novel approach.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Lui, Yvonne W — New York University School of Medicine
  • Study coordinator: Lui, Yvonne W

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.